Alzheimer's disease is the most common form of dementia ... Broadly, dementia is categorized as mild, moderate or severe — ...

These five upcoming data drops could usher in more effective and convenient therapies for Alzheimer’s disease and open up ...

Let’s keep it simple: If you want to delay Alzheimer’s onset, focus on walking and adding nutritious foods, such as walnuts, ...

Cognito’s OVERTURE trial demonstrated significant ‘time saved’ in functional and cognitive decline at both six and 18 months.

Acknowledging the limits of disease-modifying drugs like Leqembi and Kisunla, companies like Bristol Myers Squibb, Acadia, ...

Moderate coffee intake and both moderate and high tea consumption are associated with a slower decline in fluid intelligence ...

Dementia remains undiagnosed for more than 3 years on average, with young onset and frontotemporal dementia taking even ...

Quiver AI Summary Tiziana Life Sciences, Ltd. announced progress in treating moderate Alzheimer's disease with its lead candidate, intranasal foralumab, a fully human anti-CD3 monoclonal antibody.

Moderate Alzheimer’s disease (AD) patients in the trial received the highest dose of troculeucel to date at 6 billion cells per treatment. After 12 months of treatment, both patients who ...